The USDA Quandary

Jul 19, 2023

Traders in the grain trade industry are raising concerns and challenging the reliability of the U.S. Department of Agriculture (USDA) reports. These dissenting voices are deviating from the market consensus, expressing doubts about the accuracy of USDA data.

In recent times, it has been customary to avoid trading against USDA reports, as they reflect the collective market opinion. However, a growing number of traders are questioning the credibility of USDA's findings. Some suggest that the agency may be manipulating numbers or reaching predetermined conclusions. In the world of commodities trading, uncertainties persist, and traders bear the risks associated with their positions.

One area of contention is the soybean market. Traders cast doubt on USDA's projection of a 300-million-bushel carryout by year-end, arguing that the actual figure may be closer to 200 million bushels. This skepticism arises from concerns about USDA's yield estimate for this year's crop, given early development challenges and the ongoing drought. While recent rainfall has provided some relief, traders remain ready to bet on reduced yields.

In a surprising departure from their usual approach, USDA revised down the yield estimate in their July report to 177.5 bushels per acre, a record high. This adjustment caught many traders off guard, as USDA rarely changes yield projections in July. The discrepancy between USDA's estimate and the trade average of 176.1 bushels per acre further highlights the divide between market sentiment and official reports.

Amidst this uncertainty, the corn market faces its own challenges. Conversations with Midwest producers reveal mixed sentiments, as they acknowledge the positive impact of recent rainfall on crop conditions but express doubts about achieving trend-line yields due to previous drought and hail damage. Estimating crop size becomes increasingly complex due to various weather-related factors.

While USDA encounters criticism, particularly from skeptical farmers, their role in providing market information is a complex and demanding task. The market, however, continues to analyze the situation independently, seeking to navigate the discrepancies between USDA reports and traders' perceptions.

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.